Details Basic Details Date Monday, September 21, 2020 Type Presentation Materials Incidence of Severe Abnormal Uterine Bleeding Following Oral Anticoagulant Use Additional Information Information Host 36th International Conference on Pharmacoepidemiology & Therapeutic Risk Management Related Assessment(s) Incidence of Severe Uterine Bleed Following Novel Oral Anticoagulants Use: A Descriptive Analysis 36th International Conference on Pharmacoepidemiology and Therapeutic Risk Management ICPE All Access Conference Abstracts Sentinel Drug Study: Eliquis (Apixaban), Pradaxa (Dabigatran), and Xarelto (Rivaroxaban) & Severe Uterine Bleed Contributors Presenter(s) Ting-Ying Huang, Laura Hou, Abby Anderson, Hui-Lee Wong, Rongmei Zhang, Peter Waldron, David Moeny, Audrey Gassman, Efe Eworuke